Bioasis Technologies (CVE:BTI) Shares Cross Below 50 Day Moving Average – Here’s What Happened

Shares of Bioasis Technologies Inc. (CVE:BTIGet Free Report) passed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of C$0.01 and traded as low as C$0.01. Bioasis Technologies shares last traded at C$0.01, with a volume of 5,250 shares trading hands.

Bioasis Technologies Price Performance

The company has a quick ratio of 0.17, a current ratio of 0.11 and a debt-to-equity ratio of 27.88. The firm has a market capitalization of C$397,050.00, a PE ratio of -0.13 and a beta of 0.45. The firm’s fifty day simple moving average is C$0.01 and its 200-day simple moving average is C$0.01.

Bioasis Technologies Company Profile

(Get Free Report)

Bioasis Technologies Inc, a development stage biopharmaceutical company, engages in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. It is developing xB3, a platform technology for the transport of therapeutic agents across the blood-brain barrier (BBB); and the treatment of central nervous system disorders (CNS), including brain cancers, and metabolic and neurodegenerative diseases. The company's in-house development programs develop symptomatic and disease-modifying treatments for brain metastases (xB3-001), glioblastoma (xB3-002), and neurodegenerative diseases (xB3-007).

See Also

Receive News & Ratings for Bioasis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioasis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.